Korean medical and healthcare companies have won innovation awards for the world's largest electronics exhibition, CES 2024, in Las Vegas next January. In particular, medical AI solution providers and digital therapeutic device (DTx) makers for diagnostic support dominated the awardee list.The Consu
In 2022, Korea founded the Global Training Hub for Biomanufacturing (GTH-B) with the support of the World Health Organization (WHO).The GTH-B's initiatives are part of a broader effort to support low- and middle-income countries (LMICs) in developing self-sustainable vaccine production capabilities
BeiGene Korea said on Tuesday it obtained the Ministry of Food and Drug Safety’s approval for Tevimbra Inj. 100mg (ingredient: tislelizumab) to treat esophageal squamous cell carcinoma (ESCC). Specifically, anti-PD-1 immunotherapy Tevimbra has been authorized as monotherapy in adults with unresectab
Sam Chun Dang Pharmaceutical said Tuesday it has signed a contract with an unidentified distributor to supply SCD411 (ingredient aflibercept), a macular degeneration biosimilar referencing Eylea, in five European countries: Germany, Spain, Italy, Switzerland, and Austria.According to the public disc
TiumBio, a Kosdaq-listed R&D company focusing on rare diseases, said on Tuesday its investigational treatment for endometriosis, TU2670, has been officially registered by the World Health Organization (WHO) under the International Nonproprietary Name (INN), "merigolix."Merigolix is a gonadotropin-re
In an era where global health security transcends borders, World Bio Summit 2023 in Korea commenced its two-day meeting on Monday with the goal of bolstering global pandemic response capabilities.Hosted by the Ministry of Health and Welfare (MOHW) and the World Health Organization (WHO), the summit
MSD Korea held a press conference on Monday to celebrate the launch of Vaxneuvance, a 15-valent pneumococcal protein conjugate vaccine, in Korea.The event underscored the need for collaborative efforts and policies to swiftly introduce and implement the new vaccine in Korea's medical sector.Pneumoco
Medical AI company Selvas AI has acquired medical device manufacturer Mediana.Selvas AI said Monday that it has signed a business cooperation and share transfer agreement with Mediana for AI medical business. Under the agreement, Mediana Chairman Khil Moon-jong transferred 5.2 million shares (32 per
Atopic dermatitis experts have agreed that health insurance coverage standards should be relaxed to allow the cross-dosing of biologics and JAK inhibitors in cases of ineffectiveness or side effects.The Korean Atopic Dermatitis Association recently held its 23rd congress and unveiled revised “Atopic
Alcohol consumption may increase the risk of cardiovascular disease (CVD) in people with fatty liver disease, a new study has shown.The National Institutes of Health (NIH) under the Korea Disease Control and Prevention Agency (KDCA) said Monday that its research team has reached such a conclusion wh
JLK, a Korean AI healthcare solutions company, announced Monday that it has signed a clinical research agreement with faculty members at Harvard Medical School, part of Massachusetts General Hospital (MGH) in the U.S.Through collaboration with Harvard Medical School, JLK plans to validate and establ
Sitting for extended periods can have detrimental effects on your health. The narrative unfolds in 1950s London, the U.K., where scientists explored the potential disparity in heart disease risk between bus drivers and bus conductors. Their findings revealed that bus drivers faced a higher likelihoo
Researchers at the Korea Advanced Institute of Science and Technology (KAIST), in collaboration with the Korea Basic Science Institute (KBSI), have discovered a cellular protein that accelerates the toxicity leading to Alzheimer's disease, revealing a novel pathological network associated with the d
Philips Korea announced a partnership with Hankook General Hospital on Monday. Philips will provide its products and solutions to collaborate with Hankook General Hospital on clinical research and care.Through this partnership, the two organizations will contribute to the development of healthcare i
Sixty Korean scientists have been ranked among the "top 1 percent" of the world's most influential researchers. In particular, 10 of them are among the top 1 percent of researchers in clinical medicine. All of them are specialists in hematology-oncology.Clarivate, a global scholarly information anal
The International Vaccine Institute (IVI) signed a memorandum of understanding (MOU) with the University of Cambridge (UCAM), University of Hong Kong (HKU), and the Hong Kong Jockey Club Charities Trust (HKJCCT) to promote vaccine research and global health initiatives, including the establishment o
GC's Hunterase, a treatment for Hunter syndrome, has finally obtained full approval, 11 years after receiving conditional approval, the company said on Friday. After being designated as an orphan drug in September 2011, Hunterase, the world's second treatment for Hunter syndrome, received conditiona
There still are various “theories” criculating regarding the size of the medical school enrollment quota increase, but the government has once again emphasized that “nothing has been finalized yet.”At the annual meeting of the Korea Association of Medical Colleges (KAMC) on Friday, Jun Byung-wang, h
A lawsuit against a hospital seeking 1.7 billion won ($1.3 million) in indemnity for brain damage to a newborn due to medical negligence during childbirth was dismissed in the first trial, but partial compensation was awarded on appeal.Although there was no other negligence, the hospital violated it
Lunit said its chest X-ray AI imaging analysis solution, Lunit INSIGHT CXR, will be covered by national health insurance in Korea from as early as March 2024 because it has been designated as an innovative medical technology by the Ministry of Health and Welfare through the "Integrated Review and Ev